Viatris Inc. (1VTRS)
MTA
Closed
Aug 24, 2026
Day's Range
13.8352 wk Range
8.08Overview - 1VTRS - Viatris Inc.
Key Statistics
Valuation
Enterprise Value
24.03B
P/E (Trailing)
‪-4.69‬
Price / Sales (TTM)
‪1.08‬
Price / Book
‪1.32‬
EV / EBITDA
‪6.55‬
Profitability
Gross Margin
‪38.76%‬
Profit Margin
‪-2.78%‬
Operating Margin
‪12.55%‬
Return on Assets
‪2.66%‬
Return on Equity
‪-2.75%‬
Ownership
Shares Outstanding
1.15B
Float
1.14B
Held by Insiders
‪0.31%‬
Held by Institutions
‪93.28%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪14.45‬
200-Day Avg
‪12.51‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Market Cap - 1VTRS - Viatris Inc.
Peers - 1VTRS - Viatris Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
Profile Summary - 1VTRS - Viatris Inc.
About
Viatris Inc. is a global healthcare company that delivers quality medicines and innovative solutions to improve health access worldwide. It offers a dynamic portfolio spanning generics, including commoditized, complex products and biosimilars, alongside globally recognized established brands such as Lipitor, Norvasc,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
